Evotec $EVT (+1,24%) saw its share price rise sharply today after reports emerged of a possible takeover by a US pharmaceutical group. $HALO (-1,66%) have emerged. This news has caused the share price of the Hamburg-based biotechnology company, which specializes in drug discovery and development, to rise sharply. Analysts and investors are speculating about the strategic advantages such a deal could bring for both sides, particularly in a growing market for innovative drug research.
Personal opinion:
Should the takeover actually take place it would be a win-win situation for investors in both companies, as Evotec certainly has exciting projects underway.
Source:
The news is based on what I personally consider to be reputable sources. However, I do not guarantee their accuracy. No advice.
